Literature DB >> 10612651

Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities.

R Caricchio1, P L Cohen.   

Abstract

The immunologic basis of systemic lupus erythematosus (SLE) is multifactorial and still elusive. Recent advances in the field of apoptosis have suggested new paradigms for the development of lupus autoimmunity. In the present studies we examined the possibility that individual populations of T and B cells are abnormally resistant to apoptosis or that they stand out in over- or underexpressing Fas. Fas was generally overexpressed in cells freshly isolated from SLE patients but the apoptotic response to FasL was normal. We did not find increased spontaneous ongoing apoptosis in SLE lymphocytes. Normal cleavage of PARP similarly implied that the final biochemical pathway of apoptosis is relatively intact in SLE. Finally we placed special emphasis on the response of SLE patient cells to UV irradiation, especially cells from photosensitive patients, and found no difference in Fas expression. In conclusion our results indicate that SLE patients do not suffer from a major apoptotic abnormality. The results also raise questions concerning the dynamic expression of Fas and the significance of ongoing apoptosis as a risk for autoimmune disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10612651     DOI: 10.1006/cimm.1999.1576

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Apoptotic cell death and lupus.

Authors:  Philip L Cohen
Journal:  Springer Semin Immunopathol       Date:  2006-08-29

Review 2.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

Review 3.  The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus.

Authors:  Gyorgy Nagy; Andras Perl
Journal:  Clin Immunol       Date:  2006-01-10       Impact factor: 3.969

4.  T lymphocyte apoptosis in systemic lupus erythematosus patients.

Authors:  Maryam Rastin; Mahmoud Mahmoudi; Mohammadreza Hatef; Maryam Sahebari; Nafiseh Tabasi; Dariush Haghmorad; Reza Nosratabadi; Shahrzad Zamani; Mahdieh Khazaee; Mitra Masoudian
Journal:  Iran J Basic Med Sci       Date:  2013-08       Impact factor: 2.699

5.  Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus.

Authors:  Mehmet Ali Balci; Engin Atli; Hakan GüRKAN
Journal:  Arch Rheumatol       Date:  2021-01-27       Impact factor: 1.472

6.  Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Craig Grossman; Brian Niland; Ferenc Puskas; Hom Neupane; Fatme Allam; Katalin Banki; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2002-01

Review 7.  Nitric oxide, mitochondrial hyperpolarization, and T cell activation.

Authors:  Gyorgy Nagy; Agnes Koncz; David Fernandez; Andras Perl
Journal:  Free Radic Biol Med       Date:  2007-03-03       Impact factor: 7.376

8.  The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus.

Authors:  Yu-Jih Su; Tien-Tsai Cheng; Chung-Jen Chen; Wen-Chan Chiu; Chung-Yuan Hsu; Wen-Neng Chang; Nai-Wen Tsai; Chia-Te Kung; Hung-Chen Wang; Wei-Che Lin; Chih-Cheng Huang; Ya-Ting Chang; Chih-Min Su; Yi-Fang Chiang; Ben-Chung Cheng; Yu-Jun Lin; Cheng-Hsien Lu
Journal:  J Transl Med       Date:  2013-10-19       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.